NVSClinical Trials•globenewswire•
New Novartis ESC data highlights strength of cardiovascular portfolio
Sentiment:Positive (70)
Summary
PRESS RELEASE
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on August 18, 2025 by globenewswire